Skip to main content
. 2018 Aug 25;19:200–209. doi: 10.1016/j.redox.2018.08.015

Table 1.

Relative liver and brain mRNA expression of DYRK1A based upon Q-PCR data obtained from control (CTL), Cbs+/- mice with intermediate hyperhomocysteinemia (hhcy) with (hhcy/AAV) or without (hhcy) AAV2/8-DYRK1A treatment.

Genotype Relative expression of DYRK1A mRNA in liver Relative expression of DYRK1A mRNA in brain
CTL 100 ± 38 (n = 4) 100 ± 9 (n = 4)
hhcy 165 ± 20 (n = 4) 86 ± 2 (n = 4)
hhcy/AAV 540 ± 159**, $ (n = 4) 87 ± 9 (n = 4)

Data were normalized to the mean of control (CTL) mice. Data are presented as mean ± SEM. n = number of mice. * p < 0.01 (compared to CTL mice); $ p < 0.02 (compared to hhcy mice).